# Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC—Update from PACIFIC

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/three-year-overall-survival-with-durvalumab-after-chemoradiotherapy-in-stage-iii/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jhanelle E. Gray,Augusto Villegas,Davey B. Daniel,David Vicente,Shuji Murakami,Rina Hui,Takayasu Kurata,Alberto Chiappori,Ki Hyeong Lee,Byoung Chul Cho,David Planchard,Luis Paz‐Ares,Corinne Faivre‐Finn,Johan Vansteenkiste,David R. Spigel,Catherine Wadsworth,Maria Taboada,Phillip A. Dennis,Mustafa Özgüroğlu,Scott Antonia |
| Citations | 435 |
| DOI | 10.1016/j.jtho.2019.10.002 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1016/j.jtho.2019.10.002 |
| OpenAlex ID | https://openalex.org/W2980537150 |
| PMID | 31622733 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Jhanelle E. Gray](https://scholariq.org/researchers/jhanelle-e-gray/)
- [David R. Spigel](https://scholariq.org/researchers/david-r-spigel/)
- [David Planchard](https://scholariq.org/researchers/david-planchard/)
- [Alberto Chiappori](https://scholariq.org/researchers/alberto-chiappori/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.